(Q33427220)

26 July 2017

1 reference

title

Pseudoprogression and pseudoresponse: challenges in brain tumor imaging (English)

1 reference

26 July 2017

1 reference

Jennifer L Clarke

1

1 reference

26 July 2017

Susan Chang

series ordinal

2

1 reference

26 July 2017

publication date

1 May 2009

1 reference

Current Neurology and Neuroscience Reports

26 July 2017

published in

1 reference

26 July 2017

volume

9

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

241-246

1 reference

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

26 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11910-009-0035-4

Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

21 January 2018

1 reference

12 December 2020

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

1 reference

12 December 2020

Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced pe

1 reference

12 December 2020

Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.

1 reference

12 December 2020

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy

1 reference

12 December 2020

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

1 reference

12 December 2020

Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors

1 reference

12 December 2020

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

1 reference

12 December 2020

Clinical and radiographic features of peritumoral infarction following resection of glioblastoma

1 reference

12 December 2020

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

12 December 2020

Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?

1 reference

12 December 2020

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

1 reference

12 December 2020

MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.

1 reference

12 December 2020

Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.

1 reference

12 December 2020

Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.

1 reference

12 December 2020

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

1 reference

12 December 2020

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

1 reference

12 December 2020

Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury.

1 reference

12 December 2020

Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET.

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma

1 reference

12 December 2020

Transient postictal MRI changes in patients with brain tumors may mimic disease progression

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Clinical applications of PET in brain tumors

1 reference

12 December 2020

10.1007/S11910-009-0035-4

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1052174107

0 references

1 reference